Jones Microbiology Institute
Jones Microbiology Institute, also known as JMI Labs, is a leading entity in the microbiology and infectious disease diagnostics industry, headquartered in the United States with significant operations across Europe and Asia. Founded in 2001, the institute has established itself as a pioneer in antimicrobial susceptibility testing and microbiological research. JMI Labs offers a range of core services, including comprehensive laboratory testing and innovative research solutions that cater to healthcare providers and pharmaceutical companies. Their unique approach combines advanced technology with a commitment to accuracy, making them a trusted partner in the fight against infectious diseases. With a strong market position, Jones Microbiology Institute has achieved notable milestones, including collaborations with major healthcare institutions and contributions to global health initiatives. Their dedication to excellence continues to set them apart in the microbiology field.
DitchCarbon Score
How does Jones Microbiology Institute's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Development industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jones Microbiology Institute's score of 30 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jones Microbiology Institute's reported carbon emissions
Jones Microbiology Institute has set ambitious climate commitments aimed at significantly reducing its carbon emissions. Although specific emissions data for the most recent year is not available, the Institute has established a comprehensive strategy to address its carbon footprint. The Institute aims to achieve a reduction of over 30% in Scope 1 and 2 emissions and over 15% in Scope 3 emissions by 2026, using 2019 as the baseline year. This commitment aligns with a 1.5°C science-based target. Furthermore, the Institute plans to reach net zero emissions in its direct operations (covering all Scope 1 and 2 emissions) by 2030. By 2035, the goal extends to achieving net zero across the entire business, encompassing all Scope 1, 2, and 3 emissions. These initiatives reflect Jones Microbiology Institute's dedication to sustainability and its proactive approach to mitigating climate change impacts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jones Microbiology Institute is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
